StocksMedium•6 November 2026•
1 min read
CG Oncology Reports Narrower-Than-Expected Q3 2026 Loss
Key Facts
1CG Oncology reported a quarterly loss of $0.64 per share, beating the Zacks Consensus Estimate of a $0.86 loss.
2The current quarterly loss compares to a loss of $0.57 per share reported in the same period last year.
CG Oncology reported a quarterly loss of $0.64 per share for the third quarter ended September 2026. Zacks reported that these results outperformed analyst expectations, which had projected a loss of $0.86 per share.
The current quarterly loss compares to a loss of $0.57 per share reported in the same period last year. In market activity, CGON closed at $64.80 on November 5, 2026, with the stock trading between a low of $64.16 and a high of $67.34 during that session.